These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

131 related items for PubMed ID: 195812

  • 1. On the interrelationship of prostaglandin endoperoxide G2 and cyclic nucleotides in platelet function.
    Claesson HE, Malmsten C.
    Eur J Biochem; 1977 Jun 01; 76(1):277-84. PubMed ID: 195812
    [Abstract] [Full Text] [Related]

  • 2. Interrelation of prostaglandin endoperoxide (prostaglandin G2) and cyclic 3',5'-adenosine monophosphate in human blood platelets.
    Salzman EW.
    Biochim Biophys Acta; 1977 Aug 25; 499(1):48-60. PubMed ID: 196670
    [Abstract] [Full Text] [Related]

  • 3. Modulation of platelet cyclic nucleotide content by PGE1 and the prostaglandin endoperoxide PGG2.
    Miller OV, Gorman RR.
    J Cyclic Nucleotide Res; 1976 Aug 25; 2(2):79-87. PubMed ID: 177467
    [Abstract] [Full Text] [Related]

  • 4. The involvement of prostaglandin endoperoxide formation in the elevation of cyclic GMP levels during platelet aggregation.
    Glass DB, Gerrard JM, Townsend D, Carr DW, White JG, Goldberg ND.
    J Cyclic Nucleotide Res; 1977 Feb 25; 3(1):37-44. PubMed ID: 191476
    [Abstract] [Full Text] [Related]

  • 5. Physiological role of an endoperoxide in human platelets: hemostatic defect due to platelet cyclo-oxygenase deficiency.
    Malmsten C, Hamberg M, Svensson J, Samuelsson B.
    Proc Natl Acad Sci U S A; 1975 Apr 25; 72(4):1446-50. PubMed ID: 1055417
    [Abstract] [Full Text] [Related]

  • 6. Cyclic AMP inhibits synthesis of prostaglandin endoperoxide (PGG2) in human platelets.
    Malmsten C, Granström E, Samuelsson B.
    Biochem Biophys Res Commun; 1976 Jan 26; 68(2):569-76. PubMed ID: 175797
    [No Abstract] [Full Text] [Related]

  • 7. Studies on inhibition of human platelet function by sodium nitroprusside. Kinetic evaluation of the effect on aggregation and cyclic nucleotide content.
    Anfossi G, Russo I, Massucco P, Mattiello L, Balbo A, Cavalot F, Trovati M.
    Thromb Res; 2001 May 15; 102(4):319-30. PubMed ID: 11369425
    [Abstract] [Full Text] [Related]

  • 8. Inhibition of adenylate cyclase by adenosine analogues in preparations of broken and intact human platelets. Evidence for the unidirectional control of platelet function by cyclic AMP.
    Haslam RJ, Davidson MM, Desjardins JV.
    Biochem J; 1978 Oct 15; 176(1):83-95. PubMed ID: 215136
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Effect of cyclic 3',5'-guanosine monophosphate on human platelet function.
    Chiang TM, Dixit SN, Kang AH.
    J Lab Clin Med; 1976 Aug 15; 88(2):215-21. PubMed ID: 182889
    [Abstract] [Full Text] [Related]

  • 11. Role of cyclic nucleotides in rapid platelet adhesion to collagen.
    Polanowska-Grabowska R, Gear AR.
    Blood; 1994 May 01; 83(9):2508-15. PubMed ID: 7513202
    [Abstract] [Full Text] [Related]

  • 12. Investigation of the effects of phospholipase C on human platelets: evidence that aggregation induced by phospholipase C is independent of prostaglandin generation, released ADP and is modulated by cyclic AMP.
    Akbar H, Navran SS, Chang J, Miller DD, Feller DR.
    Thromb Res; 1982 Aug 15; 27(4):405-17. PubMed ID: 6293114
    [Abstract] [Full Text] [Related]

  • 13. Prostaglandin endoperoxides, thromboxane A2 and adenosine diphosphate in collagen-induced aggregation of rabbit platelets.
    Lewis GP, Watts IS.
    Br J Pharmacol; 1982 Apr 15; 75(4):623-31. PubMed ID: 6802211
    [Abstract] [Full Text] [Related]

  • 14. Inhibition of ADP-induced responses in human platelets by agents elevating the cyclic AMP level: comparison of aggregation and shape change.
    Steen VM, Holmsen H.
    Thromb Haemost; 1984 Dec 29; 52(3):333-5. PubMed ID: 6099615
    [Abstract] [Full Text] [Related]

  • 15. Platelet prostaglandin production and its implications.
    Smith JB, Ingerman CM, Silver MJ.
    Adv Prostaglandin Thromboxane Res; 1976 Dec 29; 2():747-53. PubMed ID: 983875
    [Abstract] [Full Text] [Related]

  • 16. Effet of prostaglandin E1 alone and in combination with theophylline or aspirin on collagen-induced platelet aggregation and on platelet nucleotides including adenosine 3':5'-cyclic monophosphate.
    Ball G, Brereton GG, Fulwood M, Ireland DM, Yates P.
    Biochem J; 1970 Dec 29; 120(4):709-18. PubMed ID: 4322038
    [Abstract] [Full Text] [Related]

  • 17. Effects of epoxymethano analogues of prostaglandin endoperoxides on aggregation, on release of 5-hydroxytryptamine and on the metabolism of 3',5'-cyclic AMP and cyclic GMP in human platelets.
    Best LC, McGuire MB, Martin TJ, Preston FE, Russell RG.
    Biochim Biophys Acta; 1979 Mar 22; 583(3):344-51. PubMed ID: 221045
    [No Abstract] [Full Text] [Related]

  • 18. Inhibition of PGE1-stimulated cAMP accumulation in human platelets by thromboxane a2.
    Miller OV, Johnson RA, Gorman RR.
    Prostaglandins; 1977 Apr 22; 13(4):599-609. PubMed ID: 193153
    [Abstract] [Full Text] [Related]

  • 19. Acetyl glycerylphosphorylcholine inhibition of prostaglandin I2-stimulated adenosine 3',5'-cyclic monophosphate levels in human platelets. Evidence for thromboxane A2 dependence.
    Miller OV, Ayer DE, Gorman RR.
    Biochim Biophys Acta; 1982 Jun 11; 711(3):445-51. PubMed ID: 6285985
    [Abstract] [Full Text] [Related]

  • 20. Aggregation of human blood platelets by vasopressin.
    Haslam RJ, Rosson GM.
    Am J Physiol; 1972 Oct 11; 223(4):958-67. PubMed ID: 4342380
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.